RxDoctor Payments Data

Thomas Nicholson, MD

Colon & Rectal Surgery · York, PANPI 1922081785

Payments from drug & device makers

What this record shows

This record is dominated by education: $7,500 of the $9,435 with a category attached, or 79.5%. Intuitive Surgical accounts for 83.6% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $6,448 and has fallen 76.7% since, to $1,502 in 2025.

$9,435in general payments, 2019–2025

Across 49 payments — averaging $192.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$8K
  • Axonics, Inc.$1K
  • LSI Solutions Inc$58
  • Medtronic$46
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$39
  • Braintree Laboratories, Inc.$36
  • plus $215 from 10 others

What the payments were for

  • Consulting fees$4505%
  • Speaking & faculty fees$4735%
  • Travel & lodging$190%
  • Food & beverage$97710%
  • Education$7,50079%
  • Gifts$160%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,435 in reported general payments places this provider in the 80th percentile of 108 colon & rectal surgery providers in Pennsylvania.

See all colon & rectal surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$139,105
Medicare patients
431
Services billed
766

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide17$8,877
CholestyramineCholestyramine (With Sugar)29$3,690
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine85$1,748
Metronidazole81$466
Amitriptyline Hcl48$351
Oxycodone Hcl56$228
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$168
Neomycin Sulfate32$167
Clindamycin Hcl24$164
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim24$84
Ciprofloxacin Hcl17$80
Hydromorphone Hcl14$27

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in York

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →